Myomo (MYO) Non-Current Debt (2017 - 2020)

Myomo (MYO) reported Non-Current Debt of $77892.0 for Q2 2020, down 91.24% quarter-over-quarter from $888961.0 in Q4 2019.

Myomo (MYO) Non-Current Debt (2017 - 2020) Analysis & Trends

Myomo has reported Non-Current Debt for 3 years, with the latest figure at $77892.0 in Q2 2020.

For the quarter ending Q2 2020, Non-Current Debt changed N/A year-over-year to $77892.0; the trailing twelve-month figure through Jun 2020 stood at $77892.0 (changed N/A YoY), and the FY2019 full-year result was $888961.0, changed N/A from the prior year.
Non-Current Debt for Q2 2020 stood at $77892.0, down from $888961.0 in the prior quarter.
The five-year high for Non-Current Debt was $888961.0 in Q4 2019, with the low at $77892.0 in Q2 2020.
Historically, Non-Current Debt has averaged $679942.2 across 3 years, with a median of $876458.0 in 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	29.64 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.22 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.81 Bn
10	Myomo	49.44 Mn	31.04 Mn	-	-

Download Data